Search Results - "Mitic, Gorana P"

Endocan is useful biomarker of survival and severity in sepsis by Mihajlovic, Dunja M., Lendak, Dajana F., Brkic, Snezana V., Draskovic, Biljana G., Mitic, Gorana P., Novakov Mikic, Aleksandra S., Cebovic, Tatjana N.

“…Coagulation abnormalities which occur as a consequence of endothelial changes are recognized as diagnostic criteria for sepsis, but significance of these…”
Get full text

Thrombomodulin is a Strong Predictor of Multiorgan Dysfunction Syndrome in Patients With Sepsis by Mihajlovic, Dunja M, Lendak, Dajana F, Draskovic, Biljana G, Mikic, Aleksandra S Novakov, Mitic, Gorana P, Cebovic, Tatjana N, Brkic, Snezana V

“…Biomarkers of endothelial dysfunction are not recommended for routine laboratory investigation of the outcome prognosis and prediction of the course of sepsis…”
Get more information

Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients by Vuckovic, Biljana A, Cabarkapa, Velibor S, Ilic, Tatjana A, Salatic, Iva R, Lozanov-Crvenkovic, Zagorka S, Mitic, Gorana P

“…To determine the differences in plasma homocysteine levels between three MTHFR 677 genotype subgroups in patients with thrombosis and in controls, as well as…”
Get full text

Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis by Vuckovic, Biljana A, Djeric, Mirjana J, Tomic, Branko V, Djordjevic, Valentina J, Bajkin, Branislav V, Mitic, Gorana P

“…Objective of our study is to determine whether decreased fibrinolytic activity or plasminogen activator inhibitor (PAI)-1 4G/5G polymorphism influence the risk…”
Get full text

Corrigendum to “Endocan is useful biomarker of survival and severity in sepsis” [Microvasc. Res. 93 (2014) 92–97] by Mihajlovic, Dunja M., Lendak, Dajana F., Draskovic, Biljana G., Brkic, Snezana V., Mitic, Gorana P., Novakov Mikic, Aleksandra S., Cebovic, Tatjana N.

Get full text